Hipec

• Hipec is a two-part procedure involving extensive surgery followed by heated chemotherapy directly within the abdomen.
• It is primarily used for cancers that have spread to the lining of the abdominal cavity (peritoneum).
• The heated chemotherapy aims to eliminate residual cancer cells that are not visible to the naked eye.
• This specialized treatment offers a potential survival benefit for carefully selected patients with peritoneal carcinomatosis.
• Patient selection and the expertise of the medical team are crucial for optimal outcomes.

What is Hipec (Hyperthermic Intraperitoneal Chemotherapy)?

Hipec, which stands for Hyperthermic Intraperitoneal Chemotherapy, is an advanced medical procedure designed to treat cancers that have spread to the peritoneum, the membrane lining the abdominal cavity. This specialized approach combines two distinct phases: cytoreductive surgery (CRS) and the administration of heated chemotherapy directly into the abdomen. The goal of this intensive treatment is to remove all visible tumors and then eliminate any remaining microscopic cancer cells that might lead to recurrence.

The concept behind this **Hipec treatment for cancer** is to deliver a high concentration of chemotherapy drugs directly to the affected area, minimizing systemic side effects while maximizing the drug’s impact on cancer cells. It is typically considered for patients with peritoneal carcinomatosis originating from cancers such as colorectal cancer, appendiceal cancer, ovarian cancer, and mesothelioma. The decision to perform Hipec surgery is made after careful evaluation by a multidisciplinary team, considering the patient’s overall health, the extent of cancer spread, and the primary tumor type.

How Does Hipec Work?

The effectiveness of Hipec stems from its unique two-pronged approach, which leverages both surgical precision and the enhanced efficacy of heated chemotherapy. The **Hipec procedure explained** involves a meticulous process that begins with extensive cytoreductive surgery. During this initial phase, surgeons meticulously remove all visible tumors and cancerous tissue from the abdominal cavity, a process known as “debulking.” This can involve removing parts of organs if they are affected by cancer, such as sections of the colon, spleen, or ovaries.

Once all macroscopic disease has been removed, the second phase begins. A heated chemotherapy solution, typically maintained at a temperature between 41°C and 43°C (105.8°F to 109.4°F), is circulated throughout the abdominal cavity for approximately 60 to 120 minutes. This hyperthermia, or elevated temperature, plays a crucial role in enhancing the chemotherapy’s effectiveness in several ways:

• Heat directly damages cancer cells, which are often more sensitive to temperature changes than healthy cells.
• Hyperthermia increases the penetration of chemotherapy drugs into tissues.
• It can also make cancer cells more susceptible to the effects of chemotherapy.
• The direct application ensures a high concentration of the drug reaches the peritoneal surface, where microscopic cancer cells may reside, without exposing the entire body to the same high dose.

After the circulation period, the chemotherapy solution is drained, and the abdomen is closed. This combined approach has shown promising results in improving survival rates for selected patients, particularly those with low-grade appendiceal tumors and certain types of colorectal cancer, according to studies published by institutions like the National Cancer Institute (NCI).